These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
256 related articles for article (PubMed ID: 27469420)
1. Survey of Clostridium difficile infection surveillance systems in Europe, 2011. Kola A; Wiuff C; Akerlund T; van Benthem BH; Coignard B; Lyytikäinen O; Weitzel-Kage D; Suetens C; Wilcox MH; Kuijper EJ; Gastmeier P; Euro Surveill; 2016 Jul; 21(29):. PubMed ID: 27469420 [TBL] [Abstract][Full Text] [Related]
2. How to: Surveillance of Clostridium difficile infections. Krutova M; Kinross P; Barbut F; Hajdu A; Wilcox MH; Kuijper EJ; Clin Microbiol Infect; 2018 May; 24(5):469-475. PubMed ID: 29274463 [TBL] [Abstract][Full Text] [Related]
3. Survey of diagnostic and typing capacity for Clostridium difficile infection in Europe, 2011 and 2014. van Dorp SM; Notermans DW; Alblas J; Gastmeier P; Mentula S; Nagy E; Spigaglia P; Ivanova K; Fitzpatrick F; Barbut F; Morris T; Wilcox MH; Kinross P; Suetens C; Kuijper EJ; Euro Surveill; 2016 Jul; 21(29):. PubMed ID: 27469624 [TBL] [Abstract][Full Text] [Related]
4. Hospital-based Clostridium difficile infection surveillance reveals high proportions of PCR ribotypes 027 and 176 in different areas of Poland, 2011 to 2013. Pituch H; Obuch-Woszczatyński P; Lachowicz D; Wultańska D; Karpiński P; Młynarczyk G; van Dorp SM; Kuijper EJ; Euro Surveill; 2015; 20(38):. PubMed ID: 26536049 [TBL] [Abstract][Full Text] [Related]
5. Standardised surveillance of Clostridium difficile infection in European acute care hospitals: a pilot study, 2013. van Dorp SM; Kinross P; Gastmeier P; Behnke M; Kola A; Delmée M; Pavelkovich A; Mentula S; Barbut F; Hajdu A; Ingebretsen A; Pituch H; Macovei IS; Jovanović M; Wiuff C; Schmid D; Olsen KE; Wilcox MH; Suetens C; Kuijper EJ; Euro Surveill; 2016 Jul; 21(29):. PubMed ID: 27472820 [TBL] [Abstract][Full Text] [Related]
7. Population-based surveillance of Clostridium difficile infection in Manitoba, Canada, by using interim surveillance definitions. Lambert PJ; Dyck M; Thompson LH; Hammond GW Infect Control Hosp Epidemiol; 2009 Oct; 30(10):945-51. PubMed ID: 19732008 [TBL] [Abstract][Full Text] [Related]
8. The emergence of community-onset Clostridium difficile infection in a tertiary hospital in Singapore: a cause for concern. Tan XQ; Verrall AJ; Jureen R; Riley TV; Collins DA; Lin RT; Balm MN; Chan D; Tambyah PA Int J Antimicrob Agents; 2014 Jan; 43(1):47-51. PubMed ID: 24290727 [TBL] [Abstract][Full Text] [Related]
9. Diversity of Clostridium difficile PCR ribotypes in Europe: results from the European, multicentre, prospective, biannual, point-prevalence study of Clostridium difficile infection in hospitalised patients with diarrhoea (EUCLID), 2012 and 2013. Davies KA; Ashwin H; Longshaw CM; Burns DA; Davis GL; Wilcox MH; Euro Surveill; 2016 Jul; 21(29):. PubMed ID: 27470194 [TBL] [Abstract][Full Text] [Related]
10. Clostridium difficile infection in the Republic of Ireland: results of a 1-month national surveillance and ribotyping project, March 2009. Burns K; Skally M; Solomon K; Scott L; McDermott S; O'Flanagan D; Fanning S; Kyne L; Fenelon L; Fitzpatrick F Infect Control Hosp Epidemiol; 2010 Oct; 31(10):1085-7. PubMed ID: 20731596 [No Abstract] [Full Text] [Related]
11. Comparison of Clostridium difficile Ribotypes Circulating in Australian Hospitals and Communities. Furuya-Kanamori L; Riley TV; Paterson DL; Foster NF; Huber CA; Hong S; Harris-Brown T; Robson J; Clements AC J Clin Microbiol; 2017 Jan; 55(1):216-225. PubMed ID: 27807147 [TBL] [Abstract][Full Text] [Related]
12. Emergence of Clostridium difficile tcdC variant 078 in Marseille, France. Cassir N; Fahsi N; Durand G; Lagier JC; Raoult D; Fournier PE Eur J Clin Microbiol Infect Dis; 2017 Oct; 36(10):1971-1974. PubMed ID: 28573471 [TBL] [Abstract][Full Text] [Related]
13. A pilot study in Serbia by European Clostridium difficile Infection Surveillance Network. Jovanović M; van Dorp SM; Drakulović M; Papić D; Pavić S; Jovanović S; Lešić A; Korać M; Milošević I; Kuijper EJ Acta Microbiol Immunol Hung; 2019 Dec; 67(1):42-48. PubMed ID: 31813261 [TBL] [Abstract][Full Text] [Related]
14. Changing epidemiology of Clostridium difficile infection following the introduction of a national ribotyping-based surveillance scheme in England. Wilcox MH; Shetty N; Fawley WN; Shemko M; Coen P; Birtles A; Cairns M; Curran MD; Dodgson KJ; Green SM; Hardy KJ; Hawkey PM; Magee JG; Sails AD; Wren MW Clin Infect Dis; 2012 Oct; 55(8):1056-63. PubMed ID: 22784871 [TBL] [Abstract][Full Text] [Related]
15. A comparison between National Healthcare Safety Network laboratory-identified event reporting versus traditional surveillance for Clostridium difficile infection. Durkin MJ; Baker AW; Dicks KV; Lewis SS; Chen LF; Anderson DJ; Sexton DJ; Moehring RW Infect Control Hosp Epidemiol; 2015 Feb; 36(2):125-31. PubMed ID: 25632994 [TBL] [Abstract][Full Text] [Related]
17. Community-acquired Clostridium difficile: epidemiology, ribotype, risk factors, hospital and intensive care unit outcomes, and current and emerging therapies. Ofori E; Ramai D; Dhawan M; Mustafa F; Gasperino J; Reddy M J Hosp Infect; 2018 Aug; 99(4):436-442. PubMed ID: 29410012 [TBL] [Abstract][Full Text] [Related]
18. Using electronic health information to risk-stratify rates of Clostridium difficile infection in US hospitals. Zilberberg MD; Tabak YP; Sievert DM; Derby KG; Johannes RS; Sun X; McDonald LC Infect Control Hosp Epidemiol; 2011 Jul; 32(7):649-55. PubMed ID: 21666394 [TBL] [Abstract][Full Text] [Related]
19. Ribotypes and New Virulent Strains Across Europe. Couturier J; Davies K; Gateau C; Barbut F Adv Exp Med Biol; 2018; 1050():45-58. PubMed ID: 29383663 [TBL] [Abstract][Full Text] [Related]